1. Home
  2. LEGN vs DY Comparison

LEGN vs DY Comparison

Compare LEGN & DY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • DY
  • Stock Information
  • Founded
  • LEGN 2014
  • DY 1969
  • Country
  • LEGN United States
  • DY United States
  • Employees
  • LEGN N/A
  • DY N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • DY Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • LEGN Health Care
  • DY Industrials
  • Exchange
  • LEGN Nasdaq
  • DY Nasdaq
  • Market Cap
  • LEGN 5.4B
  • DY 5.3B
  • IPO Year
  • LEGN 2020
  • DY N/A
  • Fundamental
  • Price
  • LEGN $38.96
  • DY $252.44
  • Analyst Decision
  • LEGN Strong Buy
  • DY Strong Buy
  • Analyst Count
  • LEGN 12
  • DY 10
  • Target Price
  • LEGN $73.91
  • DY $236.10
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • DY 329.5K
  • Earning Date
  • LEGN 08-08-2025
  • DY 08-20-2025
  • Dividend Yield
  • LEGN N/A
  • DY N/A
  • EPS Growth
  • LEGN N/A
  • DY 1.66
  • EPS
  • LEGN N/A
  • DY 7.89
  • Revenue
  • LEGN $728,303,000.00
  • DY $4,818,199,000.00
  • Revenue This Year
  • LEGN $65.49
  • DY $17.78
  • Revenue Next Year
  • LEGN $53.76
  • DY $7.78
  • P/E Ratio
  • LEGN N/A
  • DY $31.99
  • Revenue Growth
  • LEGN 112.46
  • DY 12.77
  • 52 Week Low
  • LEGN $27.34
  • DY $131.37
  • 52 Week High
  • LEGN $60.87
  • DY $255.42
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 66.26
  • DY 71.85
  • Support Level
  • LEGN $34.64
  • DY $246.82
  • Resistance Level
  • LEGN $39.88
  • DY $255.42
  • Average True Range (ATR)
  • LEGN 1.46
  • DY 5.37
  • MACD
  • LEGN 0.37
  • DY -0.46
  • Stochastic Oscillator
  • LEGN 87.67
  • DY 87.23

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About DY Dycom Industries Inc.

Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. Its operating companies supply telecommunications providers with a comprehensive portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services and provide underground facility locating services for various utilities, including telecommunications providers, and others. It also provides a range of construction, maintenance, and installation services, including the placement and splicing of fiber, copper, and coaxial cables. It provides services throughout the United States.

Share on Social Networks: